Polyacrylic bone cement containing erythromycin and colistin. I. In vitro bacteriological activity and diffusion properties of erythromycin, colistin and erythromycin/colistin comibination.
Erythromycin and colistin demonstrate a non-antagonistic ability to inhibit the growth of a wide variety of aerobic and anaerobic bacterial isolates. When incorporated in Surgical Simplex P Radiopaque Bone Cement, fabricated cement pellets were effective in inhibiting 98% of all anaerobic and aerobic test isolates. Separate experiments indicate that each antibiotic can diffuse from polymerized cement, and that the concentration of each antibiotic is consistently above the minimum inhibitory concentration of 96% of the isolates. We conclude that erythromycin/colistin Surgical Simplex P radiopaque Bone Cement is a worthy candidate for clinical investigation.
D001843:Bone Cements; D003091:Colistin; D004058:Diffusion; D004338:Drug Combinations; D004917:Erythromycin; D006801:Humans; D007595:Joint Prosthesis; D008826:Microbial Sensitivity Tests; D013530:Surgical Wound Infection / Q000517:prevention & control
D001843:Bone Cements; D004338:Drug Combinations; D004917:Erythromycin; D003091:Colistin